PolyPid and Azurity Pharmaceuticals are partnering to commercialize D-PLEX 100, preventing surgical site infections (SSIs), ...

Wheeler Bio, a biologics-focused CDMO, is appointing Rajesh Beri, PhD, as its new Chief Development Officer. Beri’s expertise ...

Forge Biologics, part of Ajinomoto Bio-Pharma Services, is partnering with Restore Vision on a gene therapy for retinitis ...

ACG has appointed Lalit Kasliwal as Group Chief Financial Officer (CFO), where he will lead ACG’s global finance function, ...

Bristol Myers Squibb and Hengrui Pharma have entered into global strategic collaboration and license agreements to advance a portfolio of 13 early stage programs in oncology, hematology and immunology ...

Xmoor Pharma and Evox Therapeutics have completed a technology transfer program for Evox's exosome-enabled gene editing ...

Samsung Biologics has launched an all-cash public tender offer to acquire 100% of the fully diluted share capital of ...

Natoli Engineering Company Inc. has acquired Scheu & Kniss, a company with 100+ of experience providing tablet press ...

What it takes to produce complex OSD drug products from the earliest stages of development to rapid, low-risk tech transfer ...

As artificial intelligence becomes more embedded in clinical development, the focus is shifting from capability to trust. At ...

Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, has entered a multi-target strategic ...

OXB has signed an agreement with Plowshare Therapies, a biotechnology company developing gene therapies for rare genetic ...